학술논문

Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer
Document Type
Article
Source
In: Breast Cancer Research. (Breast Cancer Research, 1 December 2020, 22(1))
Subject
Language
English
ISSN
1465542X
14655411